<DOC>
	<DOCNO>NCT01917461</DOCNO>
	<brief_summary>This observational prospective study in-vitro diagnostic ( IVD ) assay plan enroll 632 subject . The study conduct two stage : Stage A aim identify individual biomarkers construct multi-parametric diagnostic model , whereas Stage B aim test multi-parametric diagnostic model use fresh cohort patient . A collection clinical , radiological laboratory data gather order establish final diagnosis . Blood sample analyze level approximately 700 250,000 biomarkers determine use immunoassay molecular measurement respectively . A final diagnosis determine base majority decision panel three independent physician . Based final diagnosis , accuracy individual biomarkers combine set biomarkers differentiate distinct group patient evaluate .</brief_summary>
	<brief_title>Observational , Prospective Clinical Study Evaluate Biomarkers Indicators Acute Bacterial Viral Infections</brief_title>
	<detailed_description />
	<mesh_term>Infection</mesh_term>
	<mesh_term>Communicable Diseases</mesh_term>
	<mesh_term>Meningitis</mesh_term>
	<mesh_term>Gastroenteritis</mesh_term>
	<mesh_term>Bacteremia</mesh_term>
	<mesh_term>Virus Diseases</mesh_term>
	<mesh_term>Sepsis</mesh_term>
	<criteria>Patients least one month old willing ( either subject legal guardian ) sign inform consent eligible inclusion . For infectious noninfectious disease group , additional inclusion criterion meet . These include : In Infectious disease group : Peak fever &gt; 37.5°C ( 99.5°F ) Clinical suspicion acute infectious disease Symptoms duration ≤ 12 day In Noninfectious disease control group : A noninfectious disease healthy individual Patients meet one follow criterion exclude study : Evidence another episode acute infectious disease last two week Diagnosed congenital immune deficiency ( CID ) Current treatment immunosuppressive therapy : Active chemotherapy , Posttransplant drug , High dose steroid ( &gt; 1 mg/kg/day prednisone equivalent ) . Active radiotherapy Immunemodulating/suppressive drug include monoclonal antibody , intravenous immunoglobulin ( IVIG ) , cyclosporine , antiTNF agent Current treatment immune stimulant : Interleukin ( IL ) 2 , GranulocyteMonocytes/Granulocyte colonystimulating factor ( GM/GCSF ) , Interferon . An active hematological malignancy A diagnosis myelodysplastic syndrome myeloproliferative disease A proven suspect human immunodeficiency virus ( HIV ) 1 , hepatitis B virus ( HBV ) , hepatitis C virus ( HCV ) infection</criteria>
	<gender>All</gender>
	<minimum_age>1 Month</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2016</verification_date>
</DOC>